Related Experiment Video
Updated: Aug 6, 2026
Robotic Ablation of Atrial Fibrillation
Published on: May 29, 2015
Infrared augmented reality device versus standard procedure for peripheral venous catheterisation in children less
Alexandra Usclade1,2, Nathalie Blanc3, Margot Kohlmuller4
1Délégation Recherche Clinique et Innovation, CHU Clermont-Ferrand, Clermont-Ferrand, France.
Insights
The AccuVein AV400 device did not improve first-attempt peripheral venous catheter insertion success in young children with difficult venous access. This tool may still offer reassurance to healthcare professionals during the procedure.
Area of Science:
- Medical Devices
- Pediatric Care
- Vascular Access
Background:
- Peripheral venous catheter insertion is a common procedure in hospitalized children.
- Multiple attempts may be required, potentially leading to vein damage.
Purpose of the Study:
- To evaluate the AccuVein AV400 device's effectiveness in improving first-attempt peripheral venous catheter insertion success in children.
- To assess the impact of the device on pain perception in pediatric patients.
Main Methods:
- A quasi-experimental cluster randomized controlled trial adhering to CONSORT 2010 guidelines.
- The study included children under 3 years old with difficult intravenous access (DIVA Score) across three pediatric units.
- Comparison between standard practice and the use of the AccuVein AV400 device.
Main Results:
- 304 children were enrolled (156 AccuVein, 148 standard).
- No significant difference in first-attempt cannulation success rates (40.38% vs. 41.2%, p=0.6).
- No significant difference in caregiver-reported pain scores (4.8 vs. 5.0, p=0.4).
Conclusions:
- The AccuVein AV400 device did not enhance the success rate of first-attempt intravenous insertion in pediatric patients with difficult venous access.
- The device can serve as a supportive tool, potentially reassuring healthcare providers and aiding vein selection.
Aim And Objective:
The objective of this study was to evaluate the AccuVeinAV400® viewing device for peripheral venous catheter insertion in children on the first try.
Background:
Inserting a peripheral venous catheter is the most frequent invasive procedure carried out by healthcare professionals in hospitalised children. Several attempts are sometimes necessary, and veins can be damaged.
Design:
A quasi-experimental cluster randomised controlled trial based on the CONSORT 2010 guidelines.
Methods:
This randomised study comparing standard practice to the use of AccuVein400® was carried out on children who were less than 3 years old, with difficult intravenous access (DIVA Score), hospitalised in three paediatric units and who needed cannulation.
Result:
A total of 304 children were included (156 in the AccuVein arm and 148 in the standard arm). There was no significant difference between AccuVein and standard groups in age (respectively, 2.5 ± 0.9 years vs. 2.5 ± 0.8), or mean DIVA score (respectively 5.9 ± 1.3 vs. 5.5 ± 1.2). The success of cannulation on the first attempt was 40.38% in the AccuVein arm vs. 41.2% in the standard arm (p = .6). The caregiver's assessment of pain on the Face Legs Activity Cry Consolability scale was 4.8 ± 0.2 in the AccuVein arm vs. 5.0 ± 0.2 (p = .4).
Conclusions:
The use of AccuVein400® did not lead to greater success in intravenous insertion at the first attempt in children under 3 years of age with difficult intravenous access.
Relevance To Clinical Practice:
This device can therefore be used according to the healthcare professionals' situation and needs. It is widely used in paediatric wards, and our study shows that it offers a support tool that reassures healthcare professionals and helps validate their choice of vein easiest to catheterise.
More Related Videos
10:46Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology
Published on: May 26, 2015
13:48Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
Published on: April 21, 2023
